Gulf Survey of Atrial Fibrillation Events (Gulf SAFE): design and baseline characteristics of patients with atrial fibrillation in the Arab Middle East

Affiliations


Abstract

Background: Atrial fibrillation (AF) is the most common serious cardiac arrhythmia, and its prevalence is expected to increase. There is lack of data about patient characteristics, practice patterns, and outcomes of AF in the Arab Middle East.

Methods and results: The Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) is a prospective, observational registry of patients with AF with a 12-month follow-up. The registry was emergency room based. Between October 2009 and June 2010, 2043 consecutive patients with AF were enrolled from 23 hospitals in 6 Middle Eastern Gulf countries. Data were collected on a standardized case report form and entered online. Data collected included patient demographics, medical history, type of AF, treatment, and outcome of emergency room visit. If patients were admitted, details of their treatment, investigations, and outcomes during hospital stay were collected. Completion of 12-month follow-up is expected by July 2011. The mean age was 57 years, and 52% were men. The most common concomitant condition was hypertension, present in 1072 (52%) patients. At enrollment, 28% of patients had a history of coronary artery disease, 30% had diabetes, and 16% had rheumatic valve disease. History of stroke and transient ischemic attacks were reported in 9% and 4% of patients, respectively. The most common type of AF, first attack AF, occurred in 37%, whereas 19% of patients had lone AF.

Conclusions: Gulf SAFE will provide valuable insights into AF management and outcomes in the Gulf region of the Middle East.


Similar articles

Management and 1-year outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events.

Zubaid M, Rashed WA, Alsheikh-Ali AA, Al-Zakwani I, AlMahmeed W, Shehab A, Sulaiman K, Qudaimi AA, Asaad N, Amin H; Gulf Survey of Atrial Fibrillation Events (Gulf SAFE) Investigators.Angiology. 2015 May;66(5):464-71. doi: 10.1177/0003319714536980. Epub 2014 Jun 5.PMID: 24904179

Impact of Digoxin on Mortality in Patients With Atrial Fibrillation Stratified by Heart Failure: Findings From Gulf Survey of Atrial Fibrillation Events in the Middle East.

Al-Zakwani I, Panduranga P, Zubaid M, Sulaiman K, Rashed WA, Alsheikh-Ali AA, AlMahmeed W, Shehab A, Al Qudaimi A, Asaad N, Amin H.J Cardiovasc Pharmacol Ther. 2016 May;21(3):273-9. doi: 10.1177/1074248415603505. Epub 2015 Sep 3.PMID: 26341119

Baseline characteristics and management of patients with atrial fibrillation/flutter in the emergency department: results of a prospective, multicentre registry in China.

Zhang H, Yang Y, Zhu J, Shao X, Liu Y, Zhao L, Yu P, Zhang H, He Q, Gu X.Intern Med J. 2014 Aug;44(8):742-8. doi: 10.1111/imj.12487.PMID: 24893684 Clinical Trial.

Atrial fibrillation in the Middle East: unmapped, underdiagnosed, undertreated.

Al-Shamkhani W, Ayetey H, Lip GYH.Expert Rev Cardiovasc Ther. 2018 May;16(5):341-348. doi: 10.1080/14779072.2018.1457953. Epub 2018 Apr 4.PMID: 29575965 Review.

Atrial fibrillation in Middle Eastern Arabs and South Asians: a scoping review.

Salam AM, Kaddoura R, Salih V, Asopa S.Rev Cardiovasc Med. 2021 Dec 22;22(4):1185-1196. doi: 10.31083/j.rcm2204127.PMID: 34957762 Review.


Cited by

The Relation between Atrial Fibrillation Cardioversion Success Rate with Vitamin D Level in Patients Underwent Elective Cardioversion in King Abdulaziz Cardiac Center, King Abdulaziz Medical City for National Guards, Riyadh Saudi Arabia.

Hussain A, Al Anazi F, Alanazi A, Alshahrani A, Alharbi NM, Aleshaiwy TA, Alomran YA, Alshehri RM, Alasmarei NA.Heart Views. 2023 Jan-Mar;24(1):17-23. doi: 10.4103/heartviews.heartviews_80_22. Epub 2023 Feb 23.PMID: 37124431 Free PMC article.

The "obesity paradox" in patients with atrial fibrillation: Insights from the Gulf SAFE registry.

Li YG, Xie PX, Alsheikh-Ali AA, AlMahmeed W, Sulaiman K, Asaad N, Liu SW, Zubaid M, Lip GYH.Front Cardiovasc Med. 2022 Nov 30;9:1032633. doi: 10.3389/fcvm.2022.1032633. eCollection 2022.PMID: 36531711 Free PMC article.

Demographics and Risk Profile of Elderly Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study.

Alhaddad Z, Hammoudeh A, Khader Y, Alhaddad IA.Vasc Health Risk Manag. 2022 Apr 15;18:289-295. doi: 10.2147/VHRM.S360822. eCollection 2022.PMID: 35449533 Free PMC article.

Current gaps in management and timely referral of cardiorenal complications among people with type 2 diabetes mellitus in the Middle East and African countries: Expert recommendations.

Sonmez A, Sabbour H, Echtay A, Rahmah AM, Alhozali AM, Al Sabaan FS, Haddad FH, Iraqi H, Elebrashy I, Assaad SN, Bayat Z, Osar Siva Z, Hassanein M.J Diabetes. 2022 May;14(5):315-333. doi: 10.1111/1753-0407.13266. Epub 2022 Apr 17.PMID: 35434900 Free PMC article. Review.

Impact of thyroid disease in patients with atrial fibrillation: Analysis from the JoFib registry.

Al-Makhamreh H, Al-Ani A, Alkhulaifat D, Shaban L, Salah N, Almarayaty R, Al-Huneidy Y, Hammoudeh A.Ann Med Surg (Lond). 2022 Jan 29;74:103325. doi: 10.1016/j.amsu.2022.103325. eCollection 2022 Feb.PMID: 35145683 Free PMC article.


KMEL References